Valentina Mazzotta Selected Research

Valentina Mazzotta Research Topics

Disease

17	COVID-19 05/2024 - 01/2021
11	Infections 04/2024 - 07/2014
7	HIV Infections (HIV Infection) 03/2024 - 01/2023
7	Mpox (monkeypox) 02/2024 - 01/2022
4	Acquired Immunodeficiency Syndrome (AIDS) 09/2023 - 01/2022
3	Smallpox (Variola) 02/2024 - 01/2023
3	Coinfection 12/2023 - 01/2017
2	Vaccinia 02/2024 - 11/2023
2	Pneumonia (Pneumonitis) 01/2024 - 03/2023
2	Communicable Diseases (Infectious Diseases) 11/2023 - 03/2023
2	Pain (Aches) 11/2023 - 07/2014
2	Proctitis 08/2023 - 05/2023
2	Respiratory Insufficiency (Respiratory Failure) 04/2021 - 01/2021
1	Human Influenza (Influenza) 05/2024
1	Breakthrough Infections 04/2024
1	Hematologic Diseases (Blood Diseases) 04/2024
1	Liver Diseases (Liver Disease) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023
1	Disease Progression 10/2023
1	Inflammation (Inflammations) 08/2023
1	Sepsis (Septicemia) 08/2023
1	Necrosis 03/2023
1	Immune Reconstitution Inflammatory Syndrome 01/2023
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2023
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Syphilis 10/2021
1	Venous Thromboembolism 01/2021
1	Latent Tuberculosis 03/2020
1	Viremia 01/2020
1	Hepatitis C 01/2017
1	Discitis 07/2014

Drug/Important Bio-Agent (IBA)

10	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 02/2024 - 12/2022
5	VaccinesIBA 02/2024 - 09/2023
4	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2021
3	N-(2-cyanoethylene)urea (BA 1)IBA 04/2024 - 01/2023
3	tecovirimatIBA 11/2023 - 01/2023
3	mRNA VaccinesIBA 10/2023 - 01/2022
3	InterferonsIBA 09/2023 - 01/2017
2	molnupiravirIBA 05/2024 - 01/2023
2	cilgavimabIBA 04/2024 - 10/2023
2	tixagevimabIBA 04/2024 - 10/2023
2	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 02/2024 - 11/2023
2	Monoclonal AntibodiesIBA 01/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2023
2	casirivimab and imdevimab drug combinationIBA 01/2024 - 01/2022
2	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2023 - 01/2017
2	Cidofovir (Vistide)FDA Link 11/2023 - 01/2023
2	Viral DNAIBA 03/2023 - 01/2022
2	CytokinesIBA 03/2023 - 01/2021
1	Messenger RNA (mRNA)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 03/2024
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 02/2024
1	Illicit Drugs (Recreational Drugs)IBA 11/2023
1	mutalipocin IIIBA 10/2023
1	AntibodiesIBA 10/2023
1	N 30IBA 09/2023
1	Combined VaccinesIBA 09/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023
1	Adenosine Monophosphate (AMP)IBA 03/2023
1	sarilumabIBA 03/2023
1	InterleukinsIBA 03/2023
1	Interleukin-8 (Interleukin 8)IBA 03/2023
1	Interleukin-6 (Interleukin 6)IBA 03/2023
1	Interleukin-6 InhibitorsIBA 03/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	sotrovimabIBA 01/2023
1	remdesivirIBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	pembrolizumabIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	bamlanivimab and etesevimab drug combinationIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Viral RNAIBA 04/2021
1	fibrin fragment D (D-dimer)IBA 04/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2014

Therapy/Procedure

9	Therapeutics 04/2024 - 07/2014
3	Aftercare (After-Treatment) 05/2024 - 07/2014
3	Art Therapy 01/2023 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2024 - 04/2021
1	Retention in Care 02/2024
1	Transplantation 12/2023
1	Braces 07/2014
1	Conservative Treatment 07/2014